Brief: IRLAB Therapeutics Approved For Listing On Nasdaq Stockholm Main Market
23/09/2020 14:18
Sept 23 (Reuters) - IRLAB Therapeutics AB IRLABa.ST :
* IRLAB THERAPEUTICS HAS BEEN APPROVED FOR LISTING ON NASDAQ
STOCKHOLM MAIN MARKET
* FIRST DAY OF TRADING ON NASDAQ STOCKHOLM MAIN MARKET IS
EXPECTED
TO BE WEDNESDAY, SEPTEMBER 30, 2020
* LAST DAY OF TRADING ON NASDAQ FIRST NORTH PREMIER GROWTH
MARKET
IS EXPECTED TO BE TUESDAY, SEPTEMBER 29, 2020
Source text for Eikon: ID:nWkr59Q5yG
Further company coverage: IRLABa.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))